Saturday 17 October 2026
Export PBM’s income statement to Excel — free account
Psyence Biomedical Ltd.
In the quarter to September 2025, EPS was flat and free cash flow fell 707.2%, each against the same quarter a year earlier.
4.22
0.10
−2.31%
Follow PBM
A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.
| Jun '23 | Mar '23 | Dec '22 | Sep '22 | Older periods | |
|---|---|---|---|---|---|
Net Income |
(0.06) | (0.02) | 2.25 | 0.77 |
+6 more quarters Free account |
Change in other assets and liabilities |
0.17 | 0.01 | (0.64) | 0.06 | |
Operating Cash Flow |
(0.25) | (0.55) | (0.09) | (0.09) | |
Other investing activities |
0.49 | 0.69 | — | — | |
Investing cash flow |
(0.25) | 242.86 | — | — | |
Other financial activities |
0.81 | (0.83) | (1.93) | (0.93) | |
Financing cash flow |
0.49 | (242.43) | — | — | |
| Other line items | |||||
Change in Cash |
(0.01) | (0.11) | (0.09) | (0.09) |
In millions of $ except per-share values · columns are period end dates